{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:07:42Z","timestamp":1772021262281,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science, Japan","doi-asserted-by":"crossref","award":["JP25K23924"],"award-info":[{"award-number":["JP25K23924"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Mochida Memorial Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-05868-3","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:35:49Z","timestamp":1769762149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical applications for the endotoxin activity assay in sepsis: a scoping review"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-5518","authenticated-orcid":false,"given":"Yohei","family":"Komaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra M.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-1439","authenticated-orcid":false,"given":"Kent","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"5868_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2157-z","volume":"22","author":"KE Rudd","year":"2018","unstructured":"Rudd KE, Kissoon N, Limmathurotsakul D, Bory S, Mutahunga B, Seymour CW, et al. The global burden of sepsis: barriers and potential solutions. Crit Care. 2018;22:232. https:\/\/doi.org\/10.1186\/s13054-018-2157-z.","journal-title":"Crit Care"},{"key":"5868_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644\u201355. https:\/\/doi.org\/10.1378\/chest.101.6.1644.","journal-title":"Chest"},{"key":"5868_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"5868_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"5868_CR5","doi-asserted-by":"publisher","unstructured":"GBD 2021 Global Sepsis Collaborators. Global, regional, and national sepsis incidence and mortality, 1990\u20132021: a systematic analysis. Lancet Glob Health. 2025;13:e2013\u201326. https:\/\/doi.org\/10.1016\/S2214-109X(25)00356-0","DOI":"10.1016\/S2214-109X(25)00356-0"},{"key":"5868_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/10408363.2015.1123215","volume":"53","author":"A Gnauck","year":"2016","unstructured":"Gnauck A, Lentle RG, Kruger MC. Chasing a ghost?>--Issues with the determination of circulating levels of endotoxin in human blood. Crit Rev Clin Lab Sci. 2016;53:197\u2013215. https:\/\/doi.org\/10.3109\/10408363.2015.1123215.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"5868_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0022-1759(98)00003-9","volume":"212","author":"AD Romaschin","year":"1998","unstructured":"Romaschin AD, Harris DM, Ribeiro MB, Paice J, Foster DM, Walker PM, et al. A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. J Immunol Methods. 1998;212:169\u201385. https:\/\/doi.org\/10.1016\/s0022-1759(98)00003-9.","journal-title":"J Immunol Methods"},{"key":"5868_CR8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2460\/ajvr.70.10.1183","volume":"70","author":"JB Koenig","year":"2009","unstructured":"Koenig JB, Hart J, Harris DM, Cruz AM, Bienzle D. Evaluation of endotoxin activity in blood measured via neutrophil chemiluminescence in healthy horses and horses with colic. Am J Vet Res. 2009;70:1183\u20136. https:\/\/doi.org\/10.2460\/ajvr.70.10.1183.","journal-title":"Am J Vet Res"},{"key":"5868_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cimid.2007.08.004","volume":"31","author":"M Kjelgaard-Hansen","year":"2008","unstructured":"Kjelgaard-Hansen M, Wiinberg B, Aalbaek B, Olsen L, Harris D, Romaschin A, et al. Endotoxin activity in whole blood measured by neutrophil chemiluminescence is applicable to canine whole blood. Comp Immunol Microbiol Infect Dis. 2008;31:477\u201385. https:\/\/doi.org\/10.1016\/j.cimid.2007.08.004.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"5868_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-016-0155-3","volume":"6","author":"G Li Bassi","year":"2016","unstructured":"Li Bassi G, Marti JD, Xiol EA, Comaru T, De Rosa F, Rigol M, et al. The effects of direct hemoperfusion using a polymyxin B-immobilized column in a pig model of severe Pseudomonas aeruginosa pneumonia. Ann Intensive Care. 2016;6:58. https:\/\/doi.org\/10.1186\/s13613-016-0155-3.","journal-title":"Ann Intensive Care"},{"key":"5868_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/jhbp.10","volume":"21","author":"M Sato","year":"2014","unstructured":"Sato M, Matsuyama R, Kadokura T, Mori R, Kumamoto T, Nojiri K, et al. Severity and prognostic assessment of the endotoxin activity assay in biliary tract infection. J Hepatobiliary Pancreat Sci. 2014;21:120\u20137. https:\/\/doi.org\/10.1002\/jhbp.10.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"5868_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-020-00362-8","author":"P Sirivongrangson","year":"2020","unstructured":"Sirivongrangson P, Kulvichit W, Payungporn S, Pisitkun T, Chindamporn A, Peerapornratana S, et al. Endotoxemia and circulating bacteriome in severe COVID-19 patients. Intensive Care Med Exp. 2020. https:\/\/doi.org\/10.1186\/s40635-020-00362-8.","journal-title":"Intensive Care Med Exp"},{"key":"5868_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-021-00376-w","volume":"9","author":"PM Honore","year":"2021","unstructured":"Honore PM, Redant S, De Bels D. Is an EAA\u2009>\u20090.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? Intensive Care Med Exp. 2021;9:16. https:\/\/doi.org\/10.1186\/s40635-021-00376-w.","journal-title":"Intensive Care Med Exp"},{"key":"5868_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00134-017-5004-9","volume":"44","author":"T Fujii","year":"2018","unstructured":"Fujii T, Ganeko R, Kataoka Y, Furukawa TA, Featherstone R, Doi K, et al. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis\/septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018;44:167\u201378. https:\/\/doi.org\/10.1007\/s00134-017-5004-9.","journal-title":"Intensive Care Med"},{"key":"5868_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-016-0178-9","volume":"6","author":"SL Cutuli","year":"2016","unstructured":"Cutuli SL, Artigas A, Fumagalli R, Monti G, Ranieri VM, Ronco C, et al. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry. Ann Intensive Care. 2016;6:77. https:\/\/doi.org\/10.1186\/s13613-016-0178-9.","journal-title":"Ann Intensive Care"},{"key":"5868_CR16","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320:1455\u201363. https:\/\/doi.org\/10.1001\/jama.2018.14618.","journal-title":"JAMA"},{"key":"5868_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/422254","volume":"190","author":"JC Marshall","year":"2004","unstructured":"Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis United States. 2004;190:527\u201334. https:\/\/doi.org\/10.1086\/422254.","journal-title":"J Infect Dis United States"},{"key":"5868_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03055-8","volume":"11","author":"WY Lee","year":"2021","unstructured":"Lee WY, Kim HJ, Kim EY. Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study. Sci Rep. 2021;11:24132. https:\/\/doi.org\/10.1038\/s41598-021-03055-8.","journal-title":"Sci Rep"},{"key":"5868_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122701","volume":"12","author":"HS Kim","year":"2024","unstructured":"Kim HS, Lee GR, Kim EY. Diagnostic value of endotoxin activity for acute postoperative complications: a study in major abdominal surgery patients. Biomedicines. 2024;12:2701. https:\/\/doi.org\/10.3390\/biomedicines12122701.","journal-title":"Biomedicines"},{"key":"5868_CR20","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.21873\/invivo.12854","volume":"36","author":"T Namisaki","year":"2022","unstructured":"Namisaki T, Tsuji Y, Kitade M, Yorioka N, Fujinaga Y, Sawada Y, et al. Endotoxin activity reflects an increase in body temperature in cirrhotic patients with ascites undergoing cell-free and concentrated ascites reinfusion therapy. In Vivo. 2022;36:1477\u201384. https:\/\/doi.org\/10.21873\/invivo.12854.","journal-title":"In Vivo"},{"key":"5868_CR21","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44:2205\u201312. https:\/\/doi.org\/10.1007\/s00134-018-5463-7.","journal-title":"Intensive Care Med"},{"key":"5868_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04690-5","volume":"27","author":"JA Kellum","year":"2023","unstructured":"Kellum JA, Ronco C. The role of endotoxin in septic shock. Crit Care. 2023;27:400. https:\/\/doi.org\/10.1186\/s13054-023-04690-5.","journal-title":"Crit Care"},{"key":"5868_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216185","volume":"24","author":"DM Foster","year":"2023","unstructured":"Foster DM, Kellum JA. Endotoxic septic shock: diagnosis and treatment. Int J Mol Sci. 2023;24:16185. https:\/\/doi.org\/10.3390\/ijms242216185.","journal-title":"Int J Mol Sci"},{"key":"5868_CR24","doi-asserted-by":"publisher","unstructured":"Kellum JA, Kamaluddin E, Foster D. Targeted Rapid Endotoxin Adsorption: Can We Bring Precision Medicine to Sepsis? Blood Purif. 2025;1\u201312. https:\/\/doi.org\/10.1159\/000544989","DOI":"10.1159\/000544989"},{"key":"5868_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001085","volume":"94","author":"B Adamik","year":"2015","unstructured":"Adamik B, Smiechowicz J, Jakubczyk D, K\u00fcbler A. Elevated serum PCT in septic shock with endotoxemia is associated with a higher mortality rate. Medicine. 2015;94:e1085. https:\/\/doi.org\/10.1097\/MD.0000000000001085.","journal-title":"Medicine"},{"key":"5868_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"5868_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2077-y","volume":"22","author":"N Srisawat","year":"2018","unstructured":"Srisawat N, Tungsanga S, Lumlertgul N, Komaenthammasophon C, Peerapornratana S, Thamrongsat N, et al. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients. Crit Care. 2018;22:279. https:\/\/doi.org\/10.1186\/s13054-018-2077-y.","journal-title":"Crit Care"},{"key":"5868_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01224-8","volume":"13","author":"PD Wendel-Garcia","year":"2023","unstructured":"Wendel-Garcia PD, Eberle B, Kleinert E-M, Hilty MP, Blumenthal S, Spanaus K, et al. Effects of enhanced adsorption haemofiltration versus haemoadsorption in severe, refractory septic shock with high levels of endotoxemia: the ENDoX bicentric, randomized, controlled trial. Ann Intensive Care. 2023;13:127. https:\/\/doi.org\/10.1186\/s13613-023-01224-8.","journal-title":"Ann Intensive Care"},{"key":"5868_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/cc10264","volume":"15","author":"S Dholakia","year":"2011","unstructured":"Dholakia S, Inwald D, Betts H, Nadel S. Endotoxemia in pediatric critical illness--a pilot study. Crit Care. 2011;15:R141. https:\/\/doi.org\/10.1186\/cc10264.","journal-title":"Crit Care"},{"key":"5868_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000510126","volume":"50","author":"M Yaroustovsky","year":"2021","unstructured":"Yaroustovsky M, Abramyan M, Rogalskaya E, Komardina E. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery. Blood Purif. 2021;50:222\u20139. https:\/\/doi.org\/10.1159\/000510126.","journal-title":"Blood Purif"},{"key":"5868_CR31","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/SHK.0000000000001016","volume":"49","author":"M Yaroustovsky","year":"2018","unstructured":"Yaroustovsky M, Abramyan M, Komardina E, Nazarova H, Popov D, Plyushch M, et al. Selective LPS adsorption using polymyxin B-immobilized fiber cartridges in sepsis patients following cardiac surgery. Shock. 2018;49:658\u201366. https:\/\/doi.org\/10.1097\/SHK.0000000000001016.","journal-title":"Shock"},{"key":"5868_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000330323","volume":"32","author":"TI Ala-Kokko","year":"2011","unstructured":"Ala-Kokko TI, Laurila J, Koskenkari J. A new endotoxin adsorber in septic shock: observational case series. Blood Purif. 2011;32:303\u20139. https:\/\/doi.org\/10.1159\/000330323.","journal-title":"Blood Purif"},{"key":"5868_CR33","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/aor.14645","volume":"47","author":"SL Cutuli","year":"2023","unstructured":"Cutuli SL, Carelli S, Cascarano L, Cicconi S, Silvestri D, Cicetti M, et al. Clinical implications of endotoxin activity and Polymyxin-B hemoperfusion in critically ill patients with septic cardiomyopathy: a single-center, retrospective, observational study. Artif Organs. 2023;47:1865\u201373. https:\/\/doi.org\/10.1111\/aor.14645.","journal-title":"Artif Organs"},{"key":"5868_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.transproceed.2010.03.056","volume":"42","author":"G Novelli","year":"2010","unstructured":"Novelli G, Ferretti G, Poli L, Pretagostini R, Ruberto F, Perrella SM, et al. Clinical results of treatment of postsurgical endotoxin-mediated sepsis with polymyxin-B direct hemoperfusion. Transplant Proc. 2010;42:1021\u20134. https:\/\/doi.org\/10.1016\/j.transproceed.2010.03.056.","journal-title":"Transplant Proc"},{"key":"5868_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000357015","volume":"37","author":"M Yaroustovsky","year":"2014","unstructured":"Yaroustovsky M, Abramyan M, Krotenko N, Popov D, Plyushch M, Rogalskaya E, et al. Combined extracorporeal therapy for severe sepsis in patients after cardiac surgery. Blood Purif. 2014;37:39\u201346. https:\/\/doi.org\/10.1159\/000357015.","journal-title":"Blood Purif"},{"key":"5868_CR36","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2309314","author":"G Paternoster","year":"2022","unstructured":"Paternoster G, De Rosa S, Bertini P, Innelli P, Vignale R, Tripodi VF, et al. Comparative effectiveness of combined IgM -enriched immunoglobulin and extracorporeal blood purification plus standard care versus standard care for sepsis and septic shock after cardiac surgery. Rev Cardiovasc Med. 2022. https:\/\/doi.org\/10.31083\/j.rcm2309314.","journal-title":"Rev Cardiovasc Med"},{"issue":"3","key":"5868_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000499589","volume":"47","author":"F Turani","year":"2019","unstructured":"Turani F, Barchetta R, Falco M, Busatti S, Weltert L. Continuous renal replacement therapy with the adsorbing filter oXiris in septic patients: a case series. Blood Purif. 2019;47(3):1\u20135. https:\/\/doi.org\/10.1159\/000499589.","journal-title":"Blood Purif"},{"key":"5868_CR38","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/aor.14534","volume":"47","author":"SL Cutuli","year":"2023","unstructured":"Cutuli SL, De Rosa S, Ferrer R, Ruiz-Rodriguez JC, Forfori F, Ronco C, et al. Endotoxin activity trend and multi-organ dysfunction in critically ill patients with septic shock, who received Polymyxin-B hemadsorption: a multicenter, prospective, observational study. Artif Organs. 2023;47:1361\u201370. https:\/\/doi.org\/10.1111\/aor.14534.","journal-title":"Artif Organs"},{"key":"5868_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000515628","volume":"51","author":"S Peerapornratana","year":"2022","unstructured":"Peerapornratana S, Sirivongrangson P, Tungsanga S, Tiankanon K, Kulvichit W, Putcharoen O, et al. Endotoxin adsorbent therapy in severe COVID-19 pneumonia. Blood Purif. 2022;51:47\u201354. https:\/\/doi.org\/10.1159\/000515628.","journal-title":"Blood Purif"},{"key":"5868_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5301\/ijao.5000322","volume":"37","author":"M Yaroustovsky","year":"2014","unstructured":"Yaroustovsky M, Abramyan M, Krotenko N, Popov D, Plyushch M, Popok Z. Endotoxin adsorption using polymyxin B immobilized fiber cartridges in severe sepsis patients following cardiac surgery. Int J Artif Organs. 2014;37:299\u2013307. https:\/\/doi.org\/10.5301\/ijao.5000322.","journal-title":"Int J Artif Organs"},{"key":"5868_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00005-015-0348-8","volume":"63","author":"B Adamik","year":"2015","unstructured":"Adamik B, Zielinski S, Smiechowicz J, K\u00fcbler A. Endotoxin elimination in patients with septic shock: an observation study. Arch Immunol Ther Exp. 2015;63:475\u201383. https:\/\/doi.org\/10.1007\/s00005-015-0348-8.","journal-title":"Arch Immunol Ther Exp"},{"key":"5868_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44850-9","volume":"13","author":"E Forin","year":"2023","unstructured":"Forin E, Lorenzoni G, Ferrer R, De Cal M, Zanella M, Marchionna N, et al. Endotoxin removal therapy with Polymyxin B immobilized fiber column: a single center experience from EUPHAS2 registry. Sci Rep. 2023;13:17600. https:\/\/doi.org\/10.1038\/s41598-023-44850-9.","journal-title":"Sci Rep"},{"key":"5868_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-018-0465-8","author":"A Navas","year":"2018","unstructured":"Navas A, Ferrer R, Luisa Martinez M, Goma G, Gili G, Masip J, et al. Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case-control study. Ann Intensive Care. 2018. https:\/\/doi.org\/10.1186\/s13613-018-0465-8.","journal-title":"Ann Intensive Care"},{"key":"5868_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000083","volume":"2","author":"J-S Rachoin","year":"2020","unstructured":"Rachoin J-S, Foster D, Giese R, Weisberg LS, Klein DJ. Importance of endotoxin clearance in endotoxemic septic shock: an analysis from the evaluating use of PolymyxinB hemoperfusion in a randomized controlled trial of adults treated for endotoxemic septic shock (EUPHRATES) trial. Crit Care Explor. 2020;2:e0083. https:\/\/doi.org\/10.1097\/CCE.0000000000000083.","journal-title":"Crit Care Explor"},{"key":"5868_CR45","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.transproceed.2011.01.150","volume":"43","author":"G Novelli","year":"2011","unstructured":"Novelli G, Morabito V, Pugliese F, Ferretti G, Novelli S, Ianni S, et al. Management of sepsis during MARS treatment in acute on chronic liver failure. Transplant Proc. 2011;43:1085\u201390. https:\/\/doi.org\/10.1016\/j.transproceed.2011.01.150.","journal-title":"Transplant Proc"},{"key":"5868_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/aor.13900","volume":"45","author":"S De Rosa","year":"2021","unstructured":"De Rosa S, Cutuli SL, Ferrer R, Antonelli M, Ronco C. Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry. Artif Organs. 2021;45:E187. https:\/\/doi.org\/10.1111\/aor.13900.","journal-title":"Artif Organs"},{"key":"5868_CR47","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.transproceed.2012.05.057","volume":"44","author":"G Novelli","year":"2012","unstructured":"Novelli G, Morabito V, Ferretti G, Poli L, Novelli S, Ruberto F, et al. Safety of polymyxin-B-based hemoperfusion in kidney and liver transplant recipients. Transplant Proc. 2012;44:1966\u201372. https:\/\/doi.org\/10.1016\/j.transproceed.2012.05.057.","journal-title":"Transplant Proc"},{"key":"5868_CR48","doi-asserted-by":"publisher","first-page":"31EP","DOI":"10.15360\/1813-9779-2020-6-31-53","volume":"16","author":"MA Magomedov","year":"2020","unstructured":"Magomedov MA, Kim TG, Masolitin SV, Yaralian AV, Kalinin EY, Pisarev VM. Use of sorbent based on hypercrosslinked styrene-divinylbenzene copolymer with immobilized lps-selective ligand in hemoperfusion for treatment of patients with septic shock. Obshch Reanimatol. 2020;16:31EP \u2013 53. https:\/\/doi.org\/10.15360\/1813-9779-2020-6-31-53.","journal-title":"Obshch Reanimatol"},{"key":"5868_CR49","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1159\/000452602","volume":"41","author":"GM Virz\u00ec","year":"2016","unstructured":"Virz\u00ec GM, Clementi A, Brocca A, de Cal M, Marcante S, Ronco C. Cardiorenal syndrome type 5 in sepsis: role of endotoxin in cell death pathways and inflammation. Kidney Blood Press Res. 2016;41:1008\u201315. https:\/\/doi.org\/10.1159\/000452602.","journal-title":"Kidney Blood Press Res"},{"key":"5868_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MBC.0000000000000572","volume":"28","author":"B Adamik","year":"2017","unstructured":"Adamik B, Gozdzik W, Jakubczyk D, Welna M, K\u00fcbler A. Coagulation abnormalities identified by thromboelastometry in patients with severe sepsis: the relationship to endotoxemia and mortality. Blood Coagul Fibrinolysis. 2017;28:163\u201370. https:\/\/doi.org\/10.1097\/MBC.0000000000000572.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"5868_CR51","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s15010-014-0586-4","volume":"42","author":"F Mignon","year":"2014","unstructured":"Mignon F, Piagnerelli M, Van Nuffelen M, Vincent JL. Effect of empiric antibiotic treatment on plasma endotoxin activity in septic patients. Infection. 2014;42:521\u20138. https:\/\/doi.org\/10.1007\/s15010-014-0586-4.","journal-title":"Infection"},{"key":"5868_CR52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3844\/ajidsp.2014.164.166","volume":"10","author":"L Degl\u2019Innocenti","year":"2015","unstructured":"Degl\u2019Innocenti L, Di Paola F, Marianna R, Amato G. Endotoxin activity assay: an experience of a Southern-Italy hospital. Am J Infect Dis. 2015;10:164\u20136. https:\/\/doi.org\/10.3844\/ajidsp.2014.164.166.","journal-title":"Am J Infect Dis"},{"key":"5868_CR53","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jcrc.2013.02.005","volume":"28","author":"E Biagioni","year":"2013","unstructured":"Biagioni E, Venturelli C, Klein DJ, Buoncristiano M, Rumpianesi F, Busani S, et al. Endotoxin activity levels as a prediction tool for risk of deterioration in patients with sepsis not admitted to the intensive care unit: a pilot observational study. J Crit Care. 2013;28:612\u20137. https:\/\/doi.org\/10.1016\/j.jcrc.2013.02.005.","journal-title":"J Crit Care"},{"key":"5868_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160907","volume":"11","author":"S Wand","year":"2016","unstructured":"Wand S, Klages M, Kirbach C, Warszawska J, Meybohm P, Zacharowski K, et al. IgM-enriched immunoglobulin attenuates systemic endotoxin activity in early severe sepsis: a before-after cohort study. PLoS One. 2016;11:e0160907. https:\/\/doi.org\/10.1371\/journal.pone.0160907.","journal-title":"PLoS One"},{"key":"5868_CR55","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jcrc.2017.04.030","volume":"41","author":"M Bottiroli","year":"2017","unstructured":"Bottiroli M, Monti G, Pinciroli R, Vecchi I, Terzi V, Ortisi G, et al. Prevalence and clinical significance of early high Endotoxin Activity in septic shock: an observational study. J Crit Care. 2017;41:124\u20139. https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.030.","journal-title":"J Crit Care"},{"key":"5868_CR56","doi-asserted-by":"publisher","first-page":"856401","DOI":"10.1155\/2012\/856401","volume":"2012","author":"P Lentini","year":"2012","unstructured":"Lentini P, de Cal M, Clementi A, D\u2019Angelo A, Ronco C. Sepsis and AKI in ICU patients: the role of plasma biomarkers. Crit Care Res Pract. 2012;2012:856401\u2013856401. https:\/\/doi.org\/10.1155\/2012\/856401.","journal-title":"Crit Care Res Pract"},{"key":"5868_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12216887","author":"A Perrella","year":"2023","unstructured":"Perrella A, Rinaldi L, Guarino I, Bernardi FF, Castriconi M, Antropoli C, et al. Sepsis outcome after major abdominal surgery does not seem to be improved by the use of pentameric immunoglobulin IgM: a single-center retrospective analysis. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12216887.","journal-title":"J Clin Med"},{"key":"5868_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/cc12892","volume":"17","author":"A Koch","year":"2013","unstructured":"Koch A, Meesters MI, Scheller B, Boer C, Zacharowski K. Systemic endotoxin activity correlates with clot formation: an observational study in patients with early systemic inflammation and sepsis. Crit Care. 2013;17:R198. https:\/\/doi.org\/10.1186\/cc12892.","journal-title":"Crit Care"},{"key":"5868_CR59","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/SHK.0000000000000430","volume":"44","author":"C Schneider","year":"2015","unstructured":"Schneider C, Kuppinger D, Conradi S, Heeg F, Hartl WH. Temporal links between endotoxin activity levels and interleukin 6 concentrations in abdominal sepsis. Shock. 2015;44:310\u20135. https:\/\/doi.org\/10.1097\/SHK.0000000000000430.","journal-title":"Shock"},{"key":"5868_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814176","author":"M Marcello","year":"2023","unstructured":"Marcello M, Virz\u00ec GM, Marturano D, de Cal M, Marchionna N, Sgarabotto L, et al. The cytotoxic effect of septic plasma on healthy RBCs: is eryptosis a new mechanism for sepsis? Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241814176.","journal-title":"Int J Mol Sci"},{"key":"5868_CR61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/1753425916660177","volume":"22","author":"B Adamik","year":"2016","unstructured":"Adamik B, Smiechowicz J, K\u00fcbler A. The importance of early detection of endotoxemia. Innate Immun. 2016;22:503\u20139. https:\/\/doi.org\/10.1177\/1753425916660177.","journal-title":"Innate Immun"},{"key":"5868_CR62","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016452","volume":"98","author":"M Sekino","year":"2019","unstructured":"Sekino M, Funaoka H, Sato S, Egashira T, Inoue H, Yano R, et al. Association between endotoxemia and enterocyte injury and clinical course in patients with gram-positive septic shock: a posthoc analysis of a prospective observational study. Medicine. 2019;98:e16452. https:\/\/doi.org\/10.1097\/MD.0000000000016452.","journal-title":"Medicine"},{"key":"5868_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/cc11350","volume":"16","author":"A Yaguchi","year":"2012","unstructured":"Yaguchi A, Yuzawa J, Klein DJ, Takeda M, Harada T. Combining intermediate levels of the endotoxin activity assay (EAA) with other biomarkers in the assessment of patients with sepsis: results of an observational study. Crit Care. 2012;16:R88. https:\/\/doi.org\/10.1186\/cc11350.","journal-title":"Crit Care"},{"key":"5868_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7030047","author":"T Ikeda","year":"2019","unstructured":"Ikeda T, Kamohara H, Suda S, Nagura T, Tomino M, Sugi M, et al. Comparative evaluation of endotoxin activity level and various biomarkers for infection and outcome of ICU-admitted patients. Biomedicines. 2019. https:\/\/doi.org\/10.3390\/biomedicines7030047.","journal-title":"Biomedicines"},{"key":"5868_CR65","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10156-013-0567-z","volume":"19","author":"N Matsumoto","year":"2013","unstructured":"Matsumoto N, Takahashi G, Kojika M, Suzuki Y, Inoue Y, Inada K, et al. Interleukin-8 induces an elevation in the endotoxin activity assay (EAA) level: does the EAA truly measure the endotoxin level? J Infect Chemother. 2013;19:825\u201332. https:\/\/doi.org\/10.1007\/s10156-013-0567-z.","journal-title":"J Infect Chemother"},{"key":"5868_CR66","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/CCM.0b013e31827ca960","volume":"41","author":"T Kiguchi","year":"2013","unstructured":"Kiguchi T, Nakamori Y, Yamakawa K, Kitayama J, Wada D, Ogawa Y, et al. Maximal chemiluminescent intensity in response to lipopolysaccharide assessed by endotoxin activity assay on admission day predicts mortality in patients with sepsis. Crit Care Med. 2013;41:1443\u20139. https:\/\/doi.org\/10.1097\/CCM.0b013e31827ca960.","journal-title":"Crit Care Med"},{"key":"5868_CR67","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jcrc.2013.01.009","volume":"28","author":"D Katagiri","year":"2013","unstructured":"Katagiri D, Doi K, Matsubara T, Negishi K, Hamasaki Y, Nakamura K, et al. New biomarker panel of plasma neutrophil gelatinase-associated lipocalin and endotoxin activity assay for detecting sepsis in acute kidney injury. J Crit Care. 2013;28:564\u201370. https:\/\/doi.org\/10.1016\/j.jcrc.2013.01.009.","journal-title":"J Crit Care"},{"key":"5868_CR68","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jcrc.2020.01.020","volume":"56","author":"N Srisawat","year":"2020","unstructured":"Srisawat N, Kulvichit W, Tungsanga S, Peerapornratana S, Vorasitchai S, Tangkanakul C, et al. The role of neutrophil chemotaxis activity as an immunologic biomarker to predict mortality in critically-ill patients with severe sepsis. J Crit Care. 2020;56:215\u201321. https:\/\/doi.org\/10.1016\/j.jcrc.2020.01.020.","journal-title":"J Crit Care"},{"key":"5868_CR69","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/1753425913516885","volume":"20","author":"T Ikeda","year":"2014","unstructured":"Ikeda T, Ikeda K, Suda S, Ueno T. Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients. Innate Immun. 2014;20:881\u20137. https:\/\/doi.org\/10.1177\/1753425913516885.","journal-title":"Innate Immun"},{"key":"5868_CR70","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/shk.0b013e31805363c6","volume":"28","author":"DJ Klein","year":"2007","unstructured":"Klein DJ, Derzko A, Foster D, Seely AJ, Brunet F, Romaschin AD, et al. Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients. Shock. 2007;28:524\u20139. https:\/\/doi.org\/10.1097\/shk.0b013e31805363c6.","journal-title":"Shock"},{"key":"5868_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000534107","volume":"53","author":"SE Piret","year":"2024","unstructured":"Piret SE, Khan S, Fairuz F, Gholami S, Davis M, Kim CK, et al. Endotoxemia correlates with kidney function and length of stay in critically ill patients. Blood Purif. 2024;53:30\u20139. https:\/\/doi.org\/10.1159\/000534107.","journal-title":"Blood Purif"},{"key":"5868_CR72","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000518230","volume":"51","author":"S Khan","year":"2022","unstructured":"Khan S, Bolotova O, Sahib H, Foster D, Mallipattu SK. Endotoxemia in critically ill patients with COVID-19. Blood Purif. 2022;51:513\u20139. https:\/\/doi.org\/10.1159\/000518230.","journal-title":"Blood Purif"},{"key":"5868_CR73","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/cc1522","volume":"6","author":"JC Marshall","year":"2002","unstructured":"Marshall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Paice J, et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care. 2002;6:342\u20138. https:\/\/doi.org\/10.1186\/cc1522.","journal-title":"Crit Care"},{"key":"5868_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-10-8","author":"M Yaroustovsky","year":"2013","unstructured":"Yaroustovsky M, Plyushch M, Popov D, Samsonova N, Abramyan M, Popok Z, et al. Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery. J Inflamm. 2013. https:\/\/doi.org\/10.1186\/1476-9255-10-8.","journal-title":"J Inflamm"},{"key":"5868_CR75","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/CCM.0000000000005991","volume":"51","author":"J-J Chen","year":"2023","unstructured":"Chen J-J, Lai P-C, Lee T-H, Huang Y-T. Blood purification for adult patients with severe infection or sepsis\/septic shock: a network meta-analysis of randomized controlled trials. Crit Care Med. 2023;51:1777\u201389. https:\/\/doi.org\/10.1097\/CCM.0000000000005991.","journal-title":"Crit Care Med"},{"key":"5868_CR76","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.19209","volume":"3","author":"M Ostermann","year":"2020","unstructured":"Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open. 2020;3:e2019209. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.19209.","journal-title":"JAMA Netw Open"},{"key":"5868_CR77","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","volume":"28","author":"DM Maslove","year":"2022","unstructured":"Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, et al. Redefining critical illness. Nat Med. 2022;28:1141\u20138. https:\/\/doi.org\/10.1038\/s41591-022-01843-x.","journal-title":"Nat Med"},{"key":"5868_CR78","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001308","volume":"7","author":"L Molinari","year":"2025","unstructured":"Molinari L, Tidswell MA, Al-Khafaji A, Davison D, Galphin C, Kamaluddin E, et al. Organ failure, endotoxin activity, and mortality in septic shock. Crit Care Explor. 2025;7:e1308. https:\/\/doi.org\/10.1097\/CCE.0000000000001308.","journal-title":"Crit Care Explor"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-05868-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05868-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05868-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:17:09Z","timestamp":1772018229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-05868-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5868"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-05868-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DMF and JAK are employees of Spectral Medical. Other authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}